Pat Dorsey's top dividend stocks (June 2026) include Royalty Pharma plc (RPRX), a specialized biopharmaceutical company that focuses on acquiring revenue-producing royalties in the global drug market.

Pat Dorsey is the founder and manager of Dorsey Asset Management, an investment firm that emphasizes the importance of economic moats in corporate strategy. Before founding his own firm, he spent several years as the Director of Equity Research for Morningstar, where he helped develop their proprietary rating systems for competitive advantage.

Royalty Pharma plc

Royalty Pharma acts as a significant funder of innovation across the healthcare sector, acquiring royalty interests in various world-class therapies and late-stage drug candidates. The company collaborates with academic institutions, research hospitals, and non-profits to provide capital in exchange for future revenue streams from pharmaceutical sales. Pat Dorsey currently maintains a position in the company valued at $126.94M. This holding offers a current dividend yield of 1.63% and a TTM dividend rate of $0.91. From a valuation perspective, the analyst price target is $57.75, while the discounted cash flow value is calculated at $113.04.

Here's an overview of Pat Dorsey's trades in Royalty Pharma plc:

Aercap Holdings N.V.

Aercap is the largest commercial aircraft leasing company in the world, managing a massive fleet that serves airlines in nearly every major market. The firm provides essential financial and logistical solutions to the aviation industry, specializing in the acquisition, leasing, and management of commercial flight equipment. Within the portfolio, the current value of this position stands at $156.6M. The stock features a TTM dividend rate of $1.34, providing investors with a current dividend yield of 0.96%. Furthermore, analysts have established a price target of $165.0, even with a discounted cash flow value of -118.07.

Here's an overview of Pat Dorsey's trades in Aercap Holdings N.V.:

Booking Holdings Inc

Booking Holdings is a global leader in online travel and related services, operating a portfolio of consumer-facing brands like Booking.com, KAYAK, and OpenTable. The company facilitates travel arrangements across more than 220 countries, offering everything from accommodation bookings to rental cars and flight search services. Dorsey’s current portfolio position value for this travel giant is $68.83M. The firm provides a current dividend yield of 0.94% and a TTM dividend rate of $1.57. Market expectations are reflected in an analyst price target of $227.42 and a discounted cash flow value of $263.57.

Here's an overview of Pat Dorsey's trades in Booking Holdings Inc:

S&P Global Inc

S&P Global is a primary provider of transparent and independent ratings, benchmarks, and data for the world’s capital and commodity markets. The company’s essential intelligence services allow institutional investors and corporations to assess risk and identify opportunities through its specialized divisions, including S&P Global Ratings and Market Intelligence. The current value of this position in the Dorsey portfolio is $94.42M. With a TTM dividend rate of $3.85, the stock offers a current dividend yield of 0.91%. Additionally, the analyst price target for the company is $540.11, while the discounted cash flow value sits at $248.95.

Here's an overview of Pat Dorsey's trades in S&P Global Inc:

Danaher Corp.

Danaher is a global science and technology conglomerate that designs, manufactures, and markets professional, medical, industrial, and commercial products. The company’s diverse operations are focused on high-growth sectors such as diagnostics, life sciences, and environmental solutions, serving customers in hospitals and research laboratories worldwide. The current value of the Danaher position in Pat Dorsey's portfolio is $105.99M. Shareholders currently benefit from a dividend yield of 0.74% and a TTM dividend rate of $1.36. Valuation metrics show an analyst price target of $225.8 and a discounted cash flow value of $185.86.

Here's an overview of Pat Dorsey's trades in Danaher Corp.: